Article

Julie Fleshman on the Role of Nutrition in the Life of a Patient With Pancreatic Cancer

Author(s):

Julie Fleshman

Julie Fleshman, JD, MBA, president, CEO, Pancreatic Cancer Action Network, discusses the role of nutrition in the life of a patient with pancreatic cancer.

Julie Fleshman, JD, MBA, president, CEO, Pancreatic Cancer Action Network, discusses the role of nutrition in the life of a patient with pancreatic cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Image of Staci.
Image of woman, with text.
Image of woman with text.
Related Content
William Ramshaw resides in the expansive Pacific Northwest. He is a six-year survivor of pancreatic cancer. Catch up on William’s blogs here!
July 31st 2025

Writing Helped Me Heal After Pancreatic Cancer

William Ramshaw
Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.
Site Logo
July 31st 2025

Katie Couric: Advice to My Younger Self

Katie Kosko Kristie L. Kahl
In this week’s episode, we spoke with legendary broadcast journalist Katie Couric about serving as a cancer caregiver and her new initiative with Merck’s Your Cancer Game Plan, called “With Love, Me.”
Image of Tripp
July 31st 2025

Spotlighting Pancreatic Cancer Disparities in Black Communities

Ryan Scott
Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities they face in access to care.
Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer: © stock.adobe.com.
July 31st 2025

Atebimetinib Combo Shows 94% 6-Month Survival in Pancreatic Cancer

Spencer Feldman
Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses and a favorable safety profile.
William Ramshaw resides in the expansive Pacific Northwest. He is a six-year survivor of pancreatic cancer. Catch up on William’s blogs here!
July 31st 2025

Pancreatic Cancer Tried to Crash My Three Daughters’ Weddings

William Ramshaw
I was told I wouldn’t live to see my daughters’ weddings — but 12 years later, I’ve been there for two, and I’m holding out hope for the third.
From left: GAYLE S. JAMESON, M.S.N, ACNP-BC, AOCN, and ERIN PIERCE, M.S.N., APRN, FNP-C; PHOTOS BY AZULA RAUN
July 31st 2025

A Trailblazer in Oncology Nursing and Research

Erin Pierce, M.S.N., APRN, FNP-C
Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care.